Stay updated on Dara-VCd vs VTd, Maintenance with IXA Clinical Trial
Sign up to get notified when there's something new on the Dara-VCd vs VTd, Maintenance with IXA Clinical Trial page.

Latest updates to the Dara-VCd vs VTd, Maintenance with IXA Clinical Trial page
- Check5 days agoChange DetectedThe record describes a randomized Phase II trial comparing Dara-VCd with VTd for newly diagnosed multiple myeloma, followed by ixazomib maintenance with or without daratumumab. It also provides study design, participation criteria, trial locations, and measures of treatment response and survival.SummaryDifference62%

- Check12 days agoChange DetectedThe footer revision label changes from v3.7.2 to v3.8.0. The page still displays a 403 Forbidden error rather than the study record.SummaryDifference0.2%

- Check19 days agoChange DetectedA notice about NIH’s terminology transition from “Artificial Intelligence” to “Super Intelligence” appears above the page, with a link to updates and FAQs.SummaryDifference1%

- Check26 days agoChange DetectedThe footer revision identifier changes from v3.7.1 to v3.7.2 on the 403 error page.SummaryDifference0.2%

- Check33 days agoChange DetectedThe site footer revision changed from v3.7.0 to v3.7.1.SummaryDifference0.2%

- Check54 days agoChange DetectedThe page now shows a 403 Forbidden error, replacing the study record with a standard error page; as a result, core study information and navigation are no longer accessible to users.SummaryDifference19%

Stay in the know with updates to Dara-VCd vs VTd, Maintenance with IXA Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Dara-VCd vs VTd, Maintenance with IXA Clinical Trial page.